Gov. Brown Gets a Second Chance on Biosimilar Medicines
Earlier this year the FDA approved a first-of-its-kind drug: a biosimilar. This is an imitation form of a cell-derived, or biologic, medication. Biosimilars could offer patients powerful results – at reduced prices. But because these medications derive from living tissues, not a chemical formula, biosimilars and biologics are not identical. Nor do they necessarily give […]